CLINICAL_TRIALS
ClinicalTrials.gov record update
Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection: Real-world Effectiveness and Safety in Taiwan
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05092074
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:25.374742+00:00
- Published At
- 2021-11-01T00:00:00+00:00
- Record Updated At
- 2021-11-01
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Hepatitis C Virus Infection", "Treatment Side Effects", "Adherence, Treatment", "Effect of Drug"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-11-01"- protocolSection.identificationModule.nctId
"NCT05092074"- protocolSection.identificationModule.officialTitle
"Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection: Real-world Effectiveness and Safety in Taiwan"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.